NCT02549248View on ClinicalTrials.gov

Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Interstitial Lung Diseases
Interventions
OTHER

BAL

Patients with idiopathic and non idiopathic interstitial lung diseases

OTHER

BW

Patients with idiopathic and non idiopathic interstitial lung diseases

OTHER

EAC

Patients with idiopathic and non idiopathic interstitial lung diseases

OTHER

blood specimen

Patients with idiopathic and non idiopathic interstitial lung diseases

OTHER

Urine specimen

Patients with idiopathic and non idiopathic interstitial lung diseases

Trial Locations (1)

42055

Chu Saint-Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02549248 - Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology | Biotech Hunter | Biotech Hunter